Published in Acta Endocrinol (Copenh) on October 01, 1979
Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin. J Clin Invest (1989) 1.47
Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci U S A (1984) 1.30
Activity of human growth hormone and related polypeptides on the adipose conversion of 3T3 cells. Mol Cell Biol (1984) 1.01
Growth hormone promotes the differentiation of myoblasts and preadipocytes generated by azacytidine treatment of 10T1/2 cells. Proc Natl Acad Sci U S A (1984) 0.91
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science (1992) 1.45
Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. J Clin Endocrinol Metab (1992) 1.44
The human insulin-like growth factor II gene contains two development-specific promoters. FEBS Lett (1987) 1.27
Evidence for the presence of type I insulin-like growth factor receptors on rat pancreatic A and B cells. Endocrinology (1987) 1.20
Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett (1985) 1.18
Further purification and characterization of sulfation factor and thymidine factor from acromegalic plasma. J Clin Endocrinol Metab (1971) 1.18
Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin. Eur J Pediatr (1985) 1.13
Specific endonucleolytic cleavage of IGF-II mRNAs. Biochem Biophys Res Commun (1991) 1.08
Site-specific cleavage of IGF-II mRNAs requires sequence elements from two distinct regions of the IGF-II gene. Nucleic Acids Res (1992) 1.06
Biosynthetic somatomedin C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatr Res (1986) 1.04
Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res (1998) 0.96
Partial characterization of sulphation and thymidine factors in acromegalic plasma. Acta Endocrinol (Copenh) (1971) 0.91
Differential polysomal localization of human insulin-like-growth-factor-2 mRNAs in cell lines and foetal liver. Eur J Biochem (1994) 0.91
Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells. Diabetologia (1990) 0.90
Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group. Eur J Pediatr (1992) 0.89
On the nomenclature of the somatomedins and insulin-like growth factors. J Clin Endocrinol Metab (1987) 0.87
The growth of different organs of normal and dwarfed Snell mice, before and during growth hormone therapy. Acta Endocrinol (Copenh) (1981) 0.86
Expression of insulin-like growth factor-I and -II genes in rat medullary thyroid carcinoma. FEBS Lett (1987) 0.85
Thyroxine and triiodothyronine levels in Snell mice. Acta Endocrinol (Copenh) (1983) 0.85
A morphological study of the development of the tibial proximal epiphysis and growth plate of normal and dwarfed Snell mice. Growth (1983) 0.84
Influence of the four leader sequences of the human insulin-like-growth-factor-2 mRNAs on the expression of reporter genes. Eur J Biochem (1994) 0.83
Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J Endocrinol (1995) 0.82
Growth response to human growth hormone treatment in children with partial and total growth hormone deficiency. Acta Paediatr Scand (1986) 0.82
Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity. Acta Endocrinol (Copenh) (1982) 0.82
Early localization of 125-I-labelled human growth hormone in adrenals and other organs of immature hypophysectomized rats. Endocrinology (1971) 0.82
Ring chromosome 2: clinical, chromosomal, and biochemical aspects. Hum Genet (1982) 0.81
On the nomenclature of the somatomedins and insulin-like growth factors. Endocrinology (1987) 0.81
Hormonal and other inherited growth disturbances in mice with special reference to the Snell dwarf mouse. A review. Acta Endocrinol Suppl (Copenh) (1983) 0.81
Total deficiency of growth hormone and prolactin, and partial deficiency of thyroid stimulating hormone in two Dutch families: a new variant of hereditary pituitary deficiency. Horm Res (1989) 0.81
Binding of somatomedin-A and -C, NSILA-S and insulin to human placental cell membranes. Horm Res (1979) 0.80
Effect of LHRH treatment on testicular descent and hormonal response in cryptorchidism. Clin Endocrinol (Oxf) (1986) 0.79
Somatosensory evoked potentials in neonates with primary congenital hypothyroidism during the first week of therapy. Pediatr Res (1991) 0.79
Characterization of specific insulin-like growth factor (IGF)-I and IGF-II receptors on cultured rabbit articular chondrocyte membranes. J Endocrinol (1989) 0.79
Receptors for insulin-like growth factors and insulin on murine fetal cortical brain cells. Biochem Biophys Res Commun (1986) 0.79
Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice. Horm Res (1988) 0.79
Expression of recombinant human insulin-like growth factor I in mammalian cells. Mol Cell Endocrinol (1990) 0.78
Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology (1994) 0.78
Biosynthetic human growth hormone: effects on growth of Snell dwarf mice. Horm Metab Res (1985) 0.77
Effects of growth hormone and thyroxine on the relation between tibial length and the histological appearance of the proximal tibial epiphysis in Snell dwarf mice. Growth (1984) 0.77
Characterization of O-glycosylated precursors of insulin-like growth factor II by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom (1996) 0.77
In vivo and in vitro studies in a 46, XY phenotypically female infant with 17-ketosteroid reductase deficiency. Horm Metab Res (1988) 0.76
Effect of hormone treatment on spontaneous and radiation-induced chromosomal breakage in normal and dwarf mice. Mutat Res (1982) 0.76
Somatosensory evoked potentials in term and preterm infants in relation to postconceptional age and birth weight. Neuropediatrics (1990) 0.76
The influence of growth hormone, somatomedins, prolactin and thyroxine on the morphology of the proximal tibial epiphysis and growth plate of Snell dwarf mice. Growth (1983) 0.76
Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy. J Endocrinol (1994) 0.75
Methionyl human growth hormone in Turner's syndrome. Arch Dis Child (1988) 0.75
Body proportions in individuals with Turner syndrome. The Dutch Growth Hormone Working Group. Eur J Pediatr (1993) 0.75
The effect of human growth hormone therapy on skinfold thickness in growth hormone-deficient children. Eur J Pediatr (1988) 0.75
Somatosensory evoked potentials in neonatal jaundice. Acta Paediatr Scand (1990) 0.75
Serum somatomedin activity and cartilage metabolism in acutely fasted, chronically malnourished, and refed rats. Endocrinology (1979) 0.75
Molecular aspects of the human somatomedins. Horm Res (1986) 0.75
Clastogenic effects of biosynthetic human growth hormone in Snell dwarf mice and CHO cells in vitro. Mutat Res (1984) 0.75
Cellular growth in several organs of normal and dwarfed Snell mice. Acta Endocrinol (Copenh) (1982) 0.75
Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Short-term effects. Horm Res (1984) 0.75
Intra- and inter-observer variability in the assessment of testicular descent. Andrologia (1988) 0.75
Influence of growth hormone and thyroxine on cell kinetics in the proximal tibial growth plate of Snell dwarf mice. Cell Tissue Kinet (1986) 0.75
Excessive growth in a child with craniopharyngioma and growth hormone deficiency. Eur J Pediatr (1988) 0.75
Oestrogens induce an LH surge in a prepubertal patient with 45,X gonadal dysgenesis under prolonged pulsatile LRH administration. Acta Endocrinol (Copenh) (1983) 0.75
Influence of treatment on the maturation of the somesthetic pathway in infants with primary congenital hypothyroidism during the first year of life. Pediatr Res (1993) 0.75
The human somatomedin/insulin-like growth factor genes: organization and development-specific expression. J Intern Med (1989) 0.75
Prolonged pulsatile administration of luteinizing hormone-releasing hormone in prepubertal children: diagnostic and physiologic aspects. J Clin Endocrinol Metab (1985) 0.75
Islet cell function and glucose homeostasis in hypopituitary dwarfism: synergism between growth hormone and cortisone. J Pediatr (1973) 0.75
The Snell-dwarfmouse. II. Sulphate and thymidine incorporation in costal cartilage and somatomedin levels before and during growth hormone and thyroxine therapy. Acta Endocrinol (Copenh) (1978) 0.75
Advancement of skeletal age of hypopituitary children treated with thyroid hormone plus cortisone. J Pediatr (1973) 0.75
The effects of pituitary, thyroid, pancreatic and sexual hormones on body length and weight and organ weights of Snell dwarf mice. Growth (1984) 0.75
Short-term effect on growth of two doses of GRF 1-44 in children with growth hormone deficiency: comparison with growth induced by methionyl-GH administration. Horm Res (1987) 0.75
Solid-phase assay for insulin-like growth factor (IGF) binding to IGF-binding protein-3: application to the study of the effects of antibodies and heparin. J Endocrinol (1997) 0.75
On the nomenclature of the somatomedins and insulin-like growth factors. Mol Endocrinol (1987) 0.75
The somatosensory evoked potentials of normal infants: influence of filter bandpass, arousal state and number of stimuli. Brain Dev (1989) 0.75
Somatomedins. Isr J Med Sci (1975) 0.75
[Somatomedins. Structure, physiology and clinical data]. Ann Endocrinol (Paris) (1986) 0.75
Catch-up growth. Possible mechanisms. Acta Endocrinol Suppl (Copenh) (1986) 0.75
Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice. Prog Growth Factor Res (1995) 0.75